In May, the FDA approved GSK’s GSK RSV vaccine, Arexvy, forthe prevention of LRTD caused by RSV in older adults aged 60+ years. This was the first RSV vaccine for older adults to be approved ...
The European Medicines Agency (EMA) and the European Centre for Disease Control (ECDC) recommend targeting people at risk in ...
U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns. The Centers ...
New Scientist explains how the latest covid-19 booster vaccines are different from previous ones, and who should get them ...
GSK plc (GSK, GSK.L) said Japan's Ministry of Health, Labour and Welfare has approved Arexvy for the prevention of respiratory ...
Updated COVID-19 vaccines are being rolled out in the U.S., aimed at targeting the latest, prevalent variants of the disease.
(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60. Arexvy is a vaccine used for the prevention of respiratory syncytial ...
The shot will help shield newborns from RSV in the early months of life, when they're especially vulnerable to severe illness ...
Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus ...
London open The FTSE 100 is expected to open 30 points lower on Monday, having closed up 0.07% on Friday at 7,683.91.
Pfizer PFE announced that the European Commission has approved its new vaccine, Abrysvo, for the prevention of respiratory syncytial virus (RSV) in infants through immunization of their pregnant ...
U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns.
